ProxsysRx’s process for recovering lost 340B savings and revenue As we’ve noted in multiple earlier blog posts, 340B ESP is nothing short of a blatant,
As we noted in a previous post, 340B ESP is nothing less than a brazen and (in our opinion) unlawful ploy by the drug manufacturers
Making the rich richer at the expense of the poorest and most vulnerable. Why was the 340B program created? Nobody’s ever put it better than
TPAs play a critical role in any covered entity’s 340B program. It’s their job to match contract pharmacies’ prescription claims with patient data provided by
Product & Service Providers in: STAFFING SERVICESMANAGEMENT (OUTSOURCED)CONTINUING EDUCATIONCAREERS As Seen In: View ProxsysRx’s Ad:
ProxsysRx recently organized an introductory Zoom meeting between the DOPs of two health systems we serve. Tiffany Poole joined Southwest Mississippi Regional Medical Center (in
ProxsysRx has optimized dozens of 340B programs — generating tens of millions in savings & revenue for the health systems we serve — and the
For 340B-eligible hospitals dealing with increasingly tight bottom lines (which essentially means all 340B-eligible hospitals), an in-house specialty pharmacy offers enormous savings and revenue potential.
Analyze clinical volumes and prescription patterns, research past and present records for eligible prescriptions, and review 340B contract pharmacy volumes to maximize returns on agreements.
Until Congress and/or the courts give HRSA the legal authority it should have to enforce the 340B program’s regulations established by Congress in 1992, eligible
